glp-1 therapy diabetes care providers The revolution is here 💉 Approved to treat obesity and diabetes, scientists and physicians are now excited about their promise in cardiology, brain health, addiction treatment, liver disease, and even sleep Different GLP-1 therapies could be

Although overall utilization remains below 1 percent of eligible adolescents, a marked increase in adoption was observed in 2023

Mild side effects, such as nausea, bloating, constipation, and tiredness, can also happen at the beginning

It preserves mucosal integrity, accelerates epithelial regeneration, and reduces inflammatory cytokines

It is becoming a metabolic disease platform where obesity, glycemic control, cardiovascular risk, kidney protection, liver fat reduction, sleep apnea and long-term adherence are increasingly linked

Pharmaceutical development continues with next-generation formulations, including higher-dose preparations and alternative delivery systems aimed at improving convenience and adherence

Subcutaneous tissue has lower blood flow than muscle (0.03 mL/min/g versus 0.08 mL/min/g), so medications injected subQ absorb more slowly